XML 195 R182.htm IDEA: XBRL DOCUMENT v3.23.2
Reportable segments - Operating Segment Items (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement [Line Items]      
Revenue $ 10,710,578 $ 2,862,315 $ 1,817,191
Cost of sales (4,973,953) (1,772,208) (1,334,321)
Administrative expenses (142,644) (118,893) (107,017)
Finance expense (86,651) (84,626) (82,199)
Depreciation and amortization expense (244,458) (214,239) (203,912)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 20,159 11,132 8,940
Income before taxes 5,486,496 841,221 238,538
Income tax expense (1,572,212) (249,016) (70,179)
Net income (loss) 3,914,284 592,205 168,359
Assets 10,819,101 7,180,201 4,818,463
Investment accounted for under the equity method 54,386 39,824 85,993
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts 1,757,581 152,663 358,009
Liabilities 5,887,100 3,964,230 2,655,885
Impairment loss of financial assets recognized in profit or loss 3,369 (235) 4,684
Impairment loss of non-financial assets recognized in profit or loss (42,233) (6,060) (11,644)
Cash flows from operating activities 4,077,595 822,520 182,234
Cash flows used in investing activities (909,401) (1,006,943) (167,091)
Cash flows from financing activities (2,002,969) 1,206,485 (94,132)
Operating Segments      
Statement [Line Items]      
Revenue 10,710,578 2,862,315 1,817,191
Cost of sales (4,973,953) (1,772,208) (1,334,321)
Administrative expenses 0 0 0
Finance expense 0 0 0
Depreciation and amortization expense (244,458) (214,239) (203,912)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Income before taxes 5,736,625 1,090,107 482,870
Income tax expense 0 0 0
Net income (loss) 5,736,625 1,090,107 482,870
Cash flows from operating activities 0 0 0
Cash flows used in investing activities 0 0 0
Cash flows from financing activities 0 0 0
Unallocated amounts      
Statement [Line Items]      
Revenue 0   0
Cost of sales 0 0 0
Administrative expenses (142,644) (118,893) (107,017)
Finance expense (86,651) (84,626) (82,199)
Depreciation and amortization expense     0
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 20,159 11,132 8,940
Income before taxes (250,129) (248,886) (244,332)
Income tax expense (1,572,212) (249,016) (70,179)
Net income (loss) (1,822,341) (497,902) (314,511)
Assets 10,819,101 7,180,201 4,818,463
Investment accounted for under the equity method 54,386 39,824 85,993
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts 1,757,581 152,663 358,009
Liabilities 5,887,100 3,964,230 2,655,885
Impairment loss of financial assets recognized in profit or loss 3,369 (235) 4,684
Impairment loss of non-financial assets recognized in profit or loss (42,233) (6,060) (11,644)
Cash flows from operating activities 4,077,595 822,520 182,234
Cash flows used in investing activities (909,401) (1,006,943) (167,091)
Cash flows from financing activities (2,002,969) 1,206,485 (94,132)
Specialty plant nutrients      
Statement [Line Items]      
Revenue 1,172,334 908,815 701,688
Cost of sales (722,261) (646,930) (537,801)
Administrative expenses 0 0 0
Finance expense 0 0 0
Depreciation and amortization expense (63,321) (58,808) (55,335)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Income before taxes 450,073 261,885 163,887
Income tax expense 0 0 0
Net income (loss) 450,073 261,885 163,887
Cash flows from operating activities 0 0 0
Cash flows used in investing activities 0 0 0
Cash flows from financing activities 0 0 0
Iodine and its derivatives      
Statement [Line Items]      
Revenue 754,339 437,931 334,657
Cost of sales (282,100) (240,341) (168,499)
Administrative expenses 0 0 0
Finance expense 0 0 0
Depreciation and amortization expense (53,734) (41,215) (40,687)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Income before taxes 472,239 197,590 166,158
Income tax expense 0 0 0
Net income (loss) 472,239 197,590 166,158
Cash flows from operating activities 0 0 0
Cash flows used in investing activities 0 0 0
Cash flows from financing activities 0 0 0
Lithium and its derivatives      
Statement [Line Items]      
Revenue 8,152,939 936,121 383,373
Cost of sales (3,636,852) (494,794) (297,048)
Administrative expenses 0 0 0
Finance expense 0 0 0
Depreciation and amortization expense (88,510) (65,014) (56,092)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Income before taxes 4,516,087 441,327 86,325
Income tax expense 0 0 0
Net income (loss) 4,516,087 441,327 86,325
Cash flows from operating activities 0 0 0
Cash flows used in investing activities 0 0 0
Cash flows from financing activities 0 0 0
Industrial chemicals      
Statement [Line Items]      
Revenue 165,200 132,011 160,608
Cost of sales (112,247) (109,067) (119,092)
Administrative expenses 0 0 0
Finance expense 0 0 0
Depreciation and amortization expense (14,724) (13,743) (14,136)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Income before taxes 52,953 22,944 41,516
Income tax expense 0 0 0
Net income (loss) 52,953 22,944 41,516
Cash flows from operating activities 0 0 0
Cash flows used in investing activities 0 0 0
Cash flows from financing activities 0 0 0
Potassium      
Statement [Line Items]      
Revenue 437,180 416,592 209,294
Cost of sales (193,581) (253,125) (187,019)
Administrative expenses 0 0 0
Finance expense 0 0 0
Depreciation and amortization expense (24,043) (35,290) (34,570)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Income before taxes 243,599 163,467 22,275
Income tax expense 0 0 0
Net income (loss) 243,599 163,467 22,275
Cash flows from operating activities 0 0 0
Cash flows used in investing activities 0 0 0
Cash flows from financing activities 0 0 0
Other products and services      
Statement [Line Items]      
Revenue 28,586 30,845 27,571
Cost of sales (26,912) (27,951) (24,862)
Administrative expenses 0 0 0
Finance expense 0 0 0
Depreciation and amortization expense (126) (169) (3,092)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Income before taxes 1,674 2,894 2,709
Income tax expense 0 0 0
Net income (loss) 1,674 2,894 2,709
Cash flows from operating activities 0 0 0
Cash flows used in investing activities 0 0 0
Cash flows from financing activities 0 0 0
Reportable segments      
Statement [Line Items]      
Revenue 10,710,578 2,862,315 1,817,191
Cost of sales (4,973,953) (1,772,208) (1,334,321)
Administrative expenses 0 0 0
Finance expense 0 0 0
Depreciation and amortization expense (244,458) (214,239) (203,912)
The entity's interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Income before taxes 5,736,625 1,090,107 482,870
Income tax expense 0 0 0
Net income (loss) 5,736,625 1,090,107 482,870
Cash flows from operating activities 0 0 0
Cash flows used in investing activities 0 0 0
Cash flows from financing activities 0 0 0
Parent      
Statement [Line Items]      
Revenue     1,817,191
Assets 8,430,376 5,988,757  
Liabilities 3,533,744 2,807,237  
Parent | Operating Segments      
Statement [Line Items]      
Revenue 10,710,578 2,862,315 1,817,191
Parent | Unallocated amounts      
Statement [Line Items]      
Revenue 0 0 0
Parent | Specialty plant nutrients      
Statement [Line Items]      
Revenue 1,172,334 908,815 701,688
Parent | Iodine and its derivatives      
Statement [Line Items]      
Revenue 754,339 437,931 334,657
Parent | Lithium and its derivatives      
Statement [Line Items]      
Revenue 8,152,939 936,121 383,373
Parent | Industrial chemicals      
Statement [Line Items]      
Revenue 165,200 132,011 160,608
Parent | Potassium      
Statement [Line Items]      
Revenue 437,180 416,592 209,294
Parent | Other products and services      
Statement [Line Items]      
Revenue 28,586 30,845 27,571
Parent | Reportable segments      
Statement [Line Items]      
Revenue 10,710,578 2,862,315 1,817,191
Other Operating Segment      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Operating Segments      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Unallocated amounts      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Specialty plant nutrients      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Iodine and its derivatives      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Lithium and its derivatives      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Industrial chemicals      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Potassium      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Other products and services      
Statement [Line Items]      
Revenue 0 0 0
Other Operating Segment | Reportable segments      
Statement [Line Items]      
Revenue $ 0 $ 0 $ 0